BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25811984)

  • 1. S100A8/A9 stimulates keratinocyte proliferation in the development of squamous cell carcinoma of the skin via the receptor for advanced glycation-end products.
    Iotzova-Weiss G; Dziunycz PJ; Freiberger SN; Läuchli S; Hafner J; Vogl T; French LE; Hofbauer GF
    PLoS One; 2015; 10(3):e0120971. PubMed ID: 25811984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells.
    Hermani A; De Servi B; Medunjanin S; Tessier PA; Mayer D
    Exp Cell Res; 2006 Jan; 312(2):184-97. PubMed ID: 16297907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A8/A9 (calprotectin) negatively regulates G2/M cell cycle progression and growth of squamous cell carcinoma.
    Khammanivong A; Wang C; Sorenson BS; Ross KF; Herzberg MC
    PLoS One; 2013; 8(7):e69395. PubMed ID: 23874958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1.
    Eggers K; Sikora K; Lorenz M; Taubert T; Moobed M; Baumann G; Stangl K; Stangl V
    Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):353-7. PubMed ID: 21472666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.
    Volz HC; Laohachewin D; Seidel C; Lasitschka F; Keilbach K; Wienbrandt AR; Andrassy J; Bierhaus A; Kaya Z; Katus HA; Andrassy M
    Basic Res Cardiol; 2012 Mar; 107(2):250. PubMed ID: 22318783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNAX-activating protein 10 (DAP10) membrane adaptor associates with receptor for advanced glycation end products (RAGE) and modulates the RAGE-triggered signaling pathway in human keratinocytes.
    Sakaguchi M; Murata H; Aoyama Y; Hibino T; Putranto EW; Ruma IM; Inoue Y; Sakaguchi Y; Yamamoto K; Kinoshita R; Futami J; Kataoka K; Iwatsuki K; Huh NH
    J Biol Chem; 2014 Aug; 289(34):23389-402. PubMed ID: 25002577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A9 has a protective role in inflammation-induced skin carcinogenesis.
    McNeill E; Hogg N
    Int J Cancer; 2014 Aug; 135(4):798-808. PubMed ID: 24436096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of S100A8/A9 in HaCaT keratinocytes alters the rate of cell proliferation and differentiation.
    Voss A; Bode G; Sopalla C; Benedyk M; Varga G; Böhm M; Nacken W; Kerkhoff C
    FEBS Lett; 2011 Jan; 585(2):440-6. PubMed ID: 21192933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A8/A9 activate key genes and pathways in colon tumor progression.
    Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G
    Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proinflammatory effects of S100A8/A9 via TLR4 and RAGE signaling pathways in BV-2 microglial cells.
    Ma L; Sun P; Zhang JC; Zhang Q; Yao SL
    Int J Mol Med; 2017 Jul; 40(1):31-38. PubMed ID: 28498464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition.
    Yin C; Li H; Zhang B; Liu Y; Lu G; Lu S; Sun L; Qi Y; Li X; Chen W
    Breast Cancer Res Treat; 2013 Nov; 142(2):297-309. PubMed ID: 24177755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products increase expression of S100A8 and A9 via RAGE-MAPK in rat dental pulp cells.
    Nakajima Y; Inagaki Y; Kido J; Nagata T
    Oral Dis; 2015 Apr; 21(3):328-34. PubMed ID: 25098709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2.
    Ghavami S; Kerkhoff C; Chazin WJ; Kadkhoda K; Xiao W; Zuse A; Hashemi M; Eshraghi M; Schulze-Osthoff K; Klonisch T; Los M
    Biochim Biophys Acta; 2008 Feb; 1783(2):297-311. PubMed ID: 18060880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100a8/a9 released by CD11b+Gr1+ neutrophils activates cardiac fibroblasts to initiate angiotensin II-Induced cardiac inflammation and injury.
    Wu Y; Li Y; Zhang C; A X; Wang Y; Cui W; Li H; Du J
    Hypertension; 2014 Jun; 63(6):1241-50. PubMed ID: 24711518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
    Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
    Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A8/A9 regulates MMP-2 expression and invasion and migration by carcinoma cells.
    Silva EJ; Argyris PP; Zou X; Ross KF; Herzberg MC
    Int J Biochem Cell Biol; 2014 Oct; 55():279-87. PubMed ID: 25236491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC.
    Khammanivong A; Sorenson BS; Ross KF; Dickerson EB; Hasina R; Lingen MW; Herzberg MC
    Oncotarget; 2016 Mar; 7(12):14029-47. PubMed ID: 26883112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A8 and S100A9 are messengers in the crosstalk between epidermis and dermis modulating a psoriatic milieu in human skin.
    Lee Y; Jang S; Min JK; Lee K; Sohn KC; Lim JS; Im M; Lee HE; Seo YJ; Kim CD; Lee JH
    Biochem Biophys Res Commun; 2012 Jul; 423(4):647-53. PubMed ID: 22683330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway.
    Ghavami S; Rashedi I; Dattilo BM; Eshraghi M; Chazin WJ; Hashemi M; Wesselborg S; Kerkhoff C; Los M
    J Leukoc Biol; 2008 Jun; 83(6):1484-92. PubMed ID: 18339893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms.
    Kovačić M; Mitrović-Ajtić O; Beleslin-Čokić B; Djikić D; Subotički T; Diklić M; Leković D; Gotić M; Mossuz P; Čokić VP
    Cell Oncol (Dordr); 2018 Oct; 41(5):541-553. PubMed ID: 29946821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.